Publication:
Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug.

dc.contributor.authorUgalde-Arbizu, Maider
dc.contributor.authorAguilera-Correa, John Jairo
dc.contributor.authorGarcía-Almodóvar, Victoria
dc.contributor.authorOvejero-Paredes, Karina
dc.contributor.authorDíaz-García, Diana
dc.contributor.authorEsteban, Jaime
dc.contributor.authorPáez, Paulina L
dc.contributor.authorPrashar, Sanjiv
dc.contributor.authorSan Sebastian, Eider
dc.contributor.authorFilice, Marco
dc.contributor.authorGómez-Ruiz, Santiago
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderFundación ProCNICes_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)es_ES
dc.date.accessioned2023-09-15T08:54:11Z
dc.date.available2023-09-15T08:54:11Z
dc.date.issued2023-02-07
dc.description.abstractFive different silica nanoparticles functionalized with vitamin B12, a derivative of coumarin found in green plants and a minimum content of an organotin(IV) fragment (1-MSN-Sn, 2-MSN-Sn, 2-SBA-Sn, 2-FSPm-Sn and 2-FSPs-Sn), were identified as excellent anticancer agents against triple negative breast cancer, one of the most diagnosed and aggressive cancerous tumors, with very poor prognosis. Notably, compound 2-MSN-Sn shows selectivity for cancer cells and excellent luminescent properties detectable by imaging techniques once internalized. The same compound is also able to interact with and nearly eradicate biofilms of Staphylococcus aureus, the most common bacteria isolated from chronic wounds and burns, whose treatment is a clinical challenge. 2-MSN-Sn is efficiently internalized by bacteria in a biofilm state and destroys the latter through reactive oxygen species (ROS) generation. Its internalization by bacteria was also efficiently monitored by fluorescence imaging. Since silica nanoparticles are particularly suitable for oral or topical administration, and considering both its anticancer and antibacterial activity, 2-MSN-Sn represents a new dual-condition theranostic agent, based primarily on natural products or their derivatives and with only a minimum amount of a novel metallodrug.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipWe would like to thank funding from RTI2018-094322-B-I00 funded by MCIN/AEI/10.13039/ 501100011033 and by “ERDF A way of making Europe”, by the “European Union” and the University of the Basque Country UPV/EHU (GIC18/143). M.F. is grateful to Instituto de Salud Carlos III (ISCIII) for project No DTS20/00109 (AES20-ISCIII) and PI22/00789 (AES22-ISCIII). M.F. and K.O.P. acknowledge the support of Microscopy & Dynamic Imaging Unit of CNIC, Madrid, Spain. The Unit is part of the ReDiB-ICTS and has the support of FEDER, “Una manera de hacer Europa.” The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033).es_ES
dc.format.number2es_ES
dc.format.volume15es_ES
dc.identifier.citationPharmaceutics. 2023 Feb 7;15(2):560.es_ES
dc.identifier.doi10.3390/pharmaceutics15020560es_ES
dc.identifier.issn1999-4923es_ES
dc.identifier.journalPharmaceuticses_ES
dc.identifier.pubmedID36839883es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16464
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RTI2018-094322-B-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MCIN/AEI/10.13039/501100011033es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/DTS20/00109/AES20-ISCIIIes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI22/00789/AES22-ISCIIIes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MICIN/AEI/10.13039/501100011033/CEX2020-001041-Ses_ES
dc.relation.publisherversion10.3390/pharmaceutics15020560es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Unidades técnicas::Microscopíaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleDual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication0f9c6c42-a9bd-44b2-9dee-66d442bedc6d
relation.isAuthorOfPublication.latestForDiscovery0f9c6c42-a9bd-44b2-9dee-66d442bedc6d

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Dual Anticancer and Antibacterial_Pharmaceutics_2023.pdf
Size:
6.09 MB
Format:
Adobe Portable Document Format
Description:
Artículo